Litcius/Paper detail

Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus

Rensong Huang, Meng Zhang, Yu Tong, Yaran Teng, Hui Li, Wei Wu

2022Frontiers in Nutrition12 citationsDOIOpen Access PDF

Abstract

Objectives: C.A. Meyer, which is one of the widely used medicinal and edible herbs for the treatment of type 2 diabetes mellitus (T2DM). Ginsenosides are its main pharmacologically active ingredient. This study aims to clarify the material basis of total ginsenosides of red ginseng (RGW) and verify the activity of RGW in treating lipid metabolism disorders caused by T2DM. Methods: activity of RGW was verified by fatty degenerated HepG2 cells. Results: experiments by RGW treatment also significantly attenuated lipid deposition in HepG2 cells. RGW upregulated the content of 5 short-chain fatty acids in rat stools, which are related to lipid oxidation and liver gluconeogenesis. Conclusion: The total RGW were quantitatively analyzed by UHPLC-MS, and its effect on lipid metabolism of T2DM was studied. The experiment demonstrated that red ginseng can regulate lipid metabolism and improve lipid deposition, which provides a promising development for red ginseng as a functional food.

Topics & Concepts

GinsengLipid metabolismType 2 Diabetes MellitusDiabetes mellitusType 2 diabetesChemistryMetabolismCarbohydrate metabolismBiochemistryMedicineEndocrinologyAlternative medicinePathologyGinseng Biological Effects and ApplicationsPharmacological Effects of Natural CompoundsLipid metabolism and disorders
Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus | Litcius